No-Fingersticks* For Treatment Decisions

Stay on top of your diabetes management knowing you get exceptionally accurate1 readings, even with hypoglycemia, and learn how to use trend arrows.

Trend Arrows & Treatment Decisions

Talk to your health care provider to help you understand trend arrows and make more informed diabetes management decisions

There are 5 different trend arrows that show the current direction of your glucose levels, and how fast they are changing. The app uses the last 20 minutes of continuous glucose data for calculating glucose trends.

 

DOWNLOAD TREND ARROWS AND TREATMENT DECISIONS PDF

Treatment Decisions—What Would You Do

Let's see an example of a situation you may encounter. It's important to consider what has happened and what is about to happen when using Eversense E3 CGM to make treatment decisions.

Glucose below target at 75 mg/dL but rising moderately. Your glucose could rise between 30 and 60 mg/dL and could reach 135 mg/dL (75 plus 60) within 30 minutes.

It’s 9am, and you dosed insulin for your breakfast about 2 hours ago.

  • You may want to keep an eye on your glucose value and the arrow before making a treatment decision.
  • Or you may consider taking carbs
FOR MORE EXAMPLES READ YOUR EVERSENSE E3 USER GUIDE

Helpful Tips

Feel confident using your Eversense E3 CGM data to make treatment decisions.

How To Make Treatment Decisions

Before making a treatment decision from your CGM data**, you should take into account the sensor glucose value, the trend arrow, the trend graph, and any alerts from the Eversense E3 CGM System. You should not base your decisions on glucose value only or trend arrow only.

** There are other things you should also take into account such as eating, insulin and medication administration, and timing. Please consult your health care provider for personalized advice.

What Treatment Decisions You Can Make

Eversense E3 CGM can be your trusted companion supporting you not only on insulin dosing decisions, but also on type and size of meals as well as on planning and undertaking physical activity.

If in doubt, please discuss with your health care provider about how to manage insulin dosing for different types of food, and how to accurately calculate carbohydrates.

 

Use E3 Readings, Trend Arrows, And Alerts Together And Respond To Them Proactively

You can count on your Eversense E3 CGM data to respond reactively and with confidence, knowing that it remains highly accurate1, even with hypoglycemia, throughout the 6 month period.

And it is proven to detect high glucose levels correctly 99% of the time (180 mg/dL) and low glucose levels correctly 94% of the time (70 mg/dL).1

*Fingersticks are still required for calibration and when symptoms do not match readings, or while taking medications of the tetracycline class.
1. Garg, S. K. et al. (2021). Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study. Diabetes Technology & Therapeutics, 24(2), 1-9. DOI:
10.1089/dia.2021.0182.

E3 Community

Connect with us on social media and use #EversenseVibeTribe to join the Eversense community and share your E3 experience!

NEED ANSWERS?

Visit the FAQs page here to see answers to our most commonly asked questions.

Vector Smart Ob Community.png

Was this content helpful?

Yes

Somewhat

No

Discover more Tips & Tricks

INCISION CARE >

Stay in the know with the Eversense E3 and get hel...

CALIBRATION >

Learn how to set up and calibrate your system to s...

SMART TRANSMITTER >

Find out how the Eversense E3 Smart Transmitter is...

TREND ARROWS AND TREATMENT DECISIONS >

Stay on top of your diabetes management knowing yo...

GLUCOSE DATA FOR YOU >

Access your In-App Reports in the Eversense App to...

LOW AND HIGH ALERTS, AND TARGETS >

The Eversense E3 CGM System is designed to provide...

PREDICTIVE AND RATE OF CHANGE ALERTS >

Even with the best management plan, diabetes can s...

SHARING DATA WITH OTHERS >

Keep tabs on your glucose levels over time and sha...

E3 LONG TERM EXCEPTIONAL ACCURACY >

There is no other CGM system available today to of...

EVENT LOG IN EVERSENSE

Taking care of family and friends, performing at w...

TRAVELLING WITH EVERSENSE

When getting ready for traveling with diabetes, th...

GET READY FOR YOUR NEXT E3 SENSOR

Preparing for your next sensor in advance will ens...

Back to Overview

 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.